Literature DB >> 23035917

Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.

Sandy S Chang1, Shu Chen, Gail J McAvay, Mary E Tinetti.   

Abstract

OBJECTIVES: To determine the extent to which the co-occurrence of chronic obstructive pulmonary disease (COPD) and cognitive impairment affect adverse health outcomes in older adults.
DESIGN: Multicenter longitudinal cohort study.
SETTING: California, Pennsylvania, Maryland, and North Carolina. PARTICIPANTS: Three thousand ninety-three community-dwelling adults aged 65 and older from the Cardiovascular Health Study. Four hundred thirty-one had chronic obstructive pulmonary disease (COPD) at study baseline. MEASUREMENTS: Follow-up began at the second CHS visit and continued for 3 years. Spirometric criteria for airflow limitation served to establish COPD using the Lambda-Mu-Sigma method, which accounts for age-related changes in lung function. Cognitive impairment was evaluated using the modified Mini-Mental State Examination and claims data. Outcomes were respiratory-related and all-cause hospitalizations and death.
RESULTS: Participants with coexisting COPD and cognitive impairment had the highest rates of respiratory-related (adjusted hazard ratio (aHR) = 4.10, 95% confidence interval (CI) = 1.86-9.05) and all-cause hospitalizations (aHR = 1.34, 95% CI = 1.00-1.80) and death (aHR = 2.29, 95% CI = 1.18-4.45). In particular, individuals with both conditions had a 48% higher rate of all-cause hospitalizations (adjusted synergy index (aSI) = 1.48, 95% CI = 0.19-11.31) and a rate of death nearly three times as high (aSI = 2.74, 95% CI = 0.43-17.32) as the sum of risks for each respective outcome associated with having COPD or cognitive impairment alone. Nevertheless, tests for interaction were not statistically significant for the presence of synergism between the two conditions contributing to each of the outcomes. Therefore, it cannot be concluded that the combined effect of COPD and cognitive impairment is greater than additive.
CONCLUSION: Coexisting COPD and cognitive impairment have an additive effect on respiratory-related and all-cause hospitalizations and death. Optimizing outcomes in older adults with COPD and cognitive impairment will require that how to improve concurrent management of both conditions be determined.
© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2012        PMID: 23035917      PMCID: PMC3470752          DOI: 10.1111/j.1532-5415.2012.04171.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  42 in total

1.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

Authors:  Jennifer L Wolff; Barbara Starfield; Gerard Anderson
Journal:  Arch Intern Med       Date:  2002-11-11

2.  Interaction as departure from additivity in case-control studies: a cautionary note.

Authors:  Anders Skrondal
Journal:  Am J Epidemiol       Date:  2003-08-01       Impact factor: 4.897

3.  Respiratory impairment and mortality in older persons: a novel spirometric approach.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Henry Klar Yaggi; Peter H Van Ness; John Concato
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

4.  2011 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2011-03       Impact factor: 21.566

5.  Defining chronic obstructive pulmonary disease in an aging population.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2010-11       Impact factor: 5.562

6.  Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Peter H Van Ness; H Klar Yaggi; John Concato
Journal:  Respir Care       Date:  2011-05-20       Impact factor: 2.258

7.  Cognitive impairment and mortality in older primary care patients.

Authors:  T E Stump; C M Callahan; H C Hendrie
Journal:  J Am Geriatr Soc       Date:  2001-07       Impact factor: 5.562

8.  Frailty and respiratory impairment in older persons.

Authors:  Carlos A Vaz Fragoso; Paul L Enright; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Am J Med       Date:  2012-01       Impact factor: 4.965

9.  Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; H Klar Yaggi; Peter H Van Ness; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2011-09-13       Impact factor: 5.562

10.  The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use.

Authors:  Julie P W Bynum; Peter V Rabins; Wendy Weller; Marlene Niefeld; Gerard F Anderson; Albert W Wu
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

View more
  31 in total

1.  Ventilatory and integrated physiological responses to chronic hypercapnia in goats.

Authors:  Nicholas J Burgraff; Suzanne E Neumueller; Kirstyn Buchholz; Thomas M Langer; Matthew R Hodges; Lawrence Pan; Hubert V Forster
Journal:  J Physiol       Date:  2018-10-14       Impact factor: 5.182

Review 2.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

3.  Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 4.  Safety considerations of inhaled corticosteroids in the elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

5.  Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem.

Authors:  Giacomo Tondo; Fabiola De Marchi; Emanuela Terazzi; Paolo Prandi; Marta Sacchetti; Cristoforo Comi; Roberto Cantello
Journal:  Neurol Sci       Date:  2018-06-21       Impact factor: 3.307

6.  Subjective cognitive complaints and neuropsychological performance in former smokers with and without chronic obstructive pulmonary disease.

Authors:  Amanda M Brunette; Kristen E Holm; Frederick S Wamboldt; Elizabeth Kozora; David J Moser; Barry J Make; James D Crapo; Kimberly Meschede; Howard D Weinberger; Kerrie L Moreau; Russell P Bowler; Karin F Hoth
Journal:  J Clin Exp Neuropsychol       Date:  2017-08-02       Impact factor: 2.475

7.  Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life?

Authors:  Megan M Dulohery; Darrell R Schroeder; Roberto P Benzo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-10

Review 8.  Cognitive impairment in COPD: a systematic review.

Authors:  Irene Torres-Sánchez; Elisabeth Rodríguez-Alzueta; Irene Cabrera-Martos; Isabel López-Torres; Maria Paz Moreno-Ramírez; Marie Carmen Valenza
Journal:  J Bras Pneumol       Date:  2015-04-18       Impact factor: 2.624

9.  Lung function, COPD and cognitive function: a multivariable and two sample Mendelian randomization study.

Authors:  Daniel H Higbee; Raquel Granell; Gibran Hemani; George Davey Smith; James W Dodd
Journal:  BMC Pulm Med       Date:  2021-07-22       Impact factor: 3.317

10.  Examining the possible causal relationship between lung function, COPD and Alzheimer's disease: a Mendelian randomisation study.

Authors:  Daniel Higbee; Raquel Granell; Esther Walton; Roxanna Korologou-Linden; George Davey Smith; James Dodd
Journal:  BMJ Open Respir Res       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.